Diabetoiogia 9 Springer-Verlag 1985

Size: px
Start display at page:

Download "Diabetoiogia 9 Springer-Verlag 1985"

Transcription

1 Diabetlgia (1985) 28: Diabetigia 9 Springer-Verlag 1985 The effects f physical training n insulin secretin and effectiveness and n glucse metablism in besity and Type 2 (nn-insulin-dependent) diabetes mellitus M. Krtkiewski, P. L6nnrth, K. Mandrukas, Z. Wrblewski, M. Rebuff6-Scrive, G. Hlm, U. Smith and P. BjOrntrp Departments f Rehabilitatin Medicine and Plastic Surgery and the Clinical Metablic Labratry f Departments f Medicine I and II, Sahlgren's Hspital, University f GStebrg, G6tebrg, Sweden Summary. Obese subjects with nrmal glucse tlerance (n = 55), and, in anther study, a grup f patients with Type 2 (nn-insulin-dependent) diabetes (n=33), and cntrls (n= 13) matched fr bdy weight and age but with nrmal glucse tlerance, participated in an individualized physical training prgram fr 3 mnths. Under cntrlled dietary cnditins, metablic studies were perfrmed befre and in steady state after the last exercise sessin after training in the subjects shwing signs f physical training in VO2 max and heart rate measurements. N changes ccurred in bdy weight, bdy cell mass, bdy fat r adipse tissue cellularity. Oral glucse tlerance was imprved in the patients with diabetes mellitus nly. In bth diabetic and cntrl subjects initially elevated C-peptide cncentratins decreased, while lw C-peptide values increased and which was particularly prnunced in diabetic subjects with subnrmal values. Peripheral insulin values did nt change. Glucse dispsal rate measured with the glucse clamp technique was similar in diabetic patients and cntrl subjects. An imprvement was seen at bth submaximal and maximal insulin levels in bth grups, crrelating with imprvement in glucse tlerance in the diabetic subjects. N changes were fund in adipcytes in insulin binding r the antiliplytic effect f insulin at submaximal insulin levels, but there was a nrmalizatin f a decreased glucse incrpratin int triglycerides. These results indicate that bth insulin secretin and effectiveness are altered by physical training in different ways in different clinical entities. They suggest that in insulin resistant cnditins with high insulin secretin (as indicated by high C- peptide cncentratins) the increased peripheral insulin sensitivity is fllwed by a decreased insulin secretin. This is nt assciated with an imprvement f glucse tlerance. In Type 2 diabetes with lw insulin secretin, an increased insulin secretin results frm physical training, perhaps due t accmpanying sensitizatin f the autnmic nervus system. Peripheral insulin cncentratins are nt altered, suggesting that the extra insulin prduced is captured by the liver. This mechanism, as well as the imprved peripheral insulin respnsiveness seen in the whle bdy and als seen at the cellular level, prbably bth cntribute t an imprvement in glucse tlerance. Key wrds: Type 2 diabetes, besity, physical training, glucse tlerance, insulin, C-peptide, glucse damp, insulin binding, adipcytes. By traditin exercise is ne f the basic principles in the therapy f diabetes mellitus t stabilize glucse hmestasis and t imprve diabetic cntrl. The dcumentatin f such effects is, hwever, surprisingly incmplete. Only recently have well-cntrlled studies been perfrmed with the purpse f trying t better define the place f regular exercise and physical training in the therapy f diabetes mellitus. In general, the effects n glucse metablism have been mderate, f shrt duratin, r even lacking (1-3), in spite f the nw well-established fact that increased levels f plasma insulin are clearly lwered by physical training due t an increased peripheral insulin sensitivity (4). These findings suggest that, at best, nly a subgrup f Type 2 (nn-insulin-dependent) patients benefits frm physical training. In the present wrk this pssibility was elucidated by subjecting sufficiently large grups f diabetic and bese subjects and cntrls t physical training t allw an analysis f effects in subgrups, characterized in terms f glucse intlerance as well as secretin, peripheral uptake and effectiveness f insulin. Changes in these variables were registered after physical training in an attempt t explain hw alteratins in glucse tlerance are brught abut. Subjects and methds Subjects examined Study L Fifty-five bese wmen were recruited frm the Obesity Outpatient Clinic at the University Hspital. They were all in a nn-dieting, weight-stable cnditin, bdy weight changing less than 2 kg

2 882 M. Krtkiewski et al.: Training in diabetes within the preceeding three mnths. They all had a nn-diabetic glucse tlerance test (fr definitin, see belw). Nn-bese cntrl wmen (n= 15) were fund amng vlunteers btained by an advertisement in a lcal newspaper. They were weightstable, healthy and nn-dieting. Mst f these wmen were physically active t sme extent, but nne was training regularly. N subjects were taking cntraceptive drugs r any ther drugs f knwn imprtance fr the examined variables. All the cntrls had nrmal glucse tlerance tests. The bdy cmpsitin and ther characteristics f these subjects are seen in Table 1. Study H. Frty-six subjects, 34 wmen and 12men, were recruited frm the Diabetes r Obesity Outpatient Clinics at the University Hspital r by an advertisement in a lcal newspaper fr participatin in the study. The general characteristics f the patients are summarized in Table 2. The subjects had a histry f weight stability (_+ - 2 kg bdy weight) during at least the preceeding 3 mnths. They were then bserved fr abut tw mnths t ensure weight stability by bdy weight recrdings at least twice during this perid. All were actively emplyed but had a rather sendentary way f life, nt training regularly r being engaged in any kind f sprts activity. Nne was n a diet except patients with knwn Type2 diabetes (12men and 12 wmen). These subjects were als treated with sulfnylurea drugs fr at least 1 year. This medicatin was nt changed during the perid f physical training, and n subject was n insulin treatment. N subject had bvius signs r symptms f diabetic cmplicatins, and the mean diabetes duratin was 5.1 years. Of the 46 subjects participating in study II glucse tlerance tests revealed that 13 had a nrmal glucse tlerance (fr definitin, see belw), while the remaining (n = 33) had decreased glucse tlerance f varying degrees including vert clinical diabetes mellitus (n=24) and were examined in ne grup. Five days prir t, as well as after the physical training perid, the patients were placed n a diet estimated t give calric balance, viz. 35 kcal per kg ideal bdy weight. Ideal bdy weight was taken frm the Metrplitan Life Insurance tables as the mean f the value given at medium frame. The diet cnsisted f abut 15, 40 and 45% f prtein, fat and carbhydrate, respectively, and was identical befre and after the perid f physical training. Glucse tlerance tests and the euglycaemic glucse clamp were perfrmed under these cnditins n the furth day r later after the last exercise sessin. All participants were instructed nt t change their rdinary diet during the training perid. All participants gave their infrmed cnsent befre entering int the examinatins. The study was apprved by the Ethical Cmmittee at the University f Grtebrg. Oral glucse tlerance test (OGT1). One hundred grams glucse, disslved in 200ml lemn flavured water, were taken rally in the mrning in the vernight fasting state. The subjects were asked nt t smke that mrning and arrive t the labratry withut rush. Bld samples were drawn befre and at 30, 60, 90 and 120 min after glucse ingestin frm an indwelling catheter in an antecubital vein fr enzymatic determinatin f bld glucse (GLOX, Kabi, Sweden), plasma insulin and cnnecting C-peptide by cmmercially available radiimmunassaymethds (Phadebas Pharmacia,Uppsala, Swedenand Nv, Cpenhagen, Denmark respectively). The errr f these methds are < 0.05% in the mean range f the analysed results. With this test the subjects were classified as diabetic if at least three glucse values exceeded the ranges prpsed by the Diabetes Data Grup [5]. Bdy cmpsitin determinatins Bdy weight was recrded t the nearest 0.1 kg and height t the nearest cm. Ttal bdy ptassium was measured in a whle bdy cunter, after crrectin fr the shielding effect f bdy fat [6]. Lean bdy mass (LBM) and bdy fat were then calculated as described by Frbes et al. [7]. Subcutaneus needle bipsies f adipse tissue were perfrmed in the epigastric, hypgastric, femral, gluteal and upper arm regins fr determinatins f fat cell weight with a micrscpic methd [8]. These values were averaged. Ttal fat cell number was estimated by dividing bdy fat with the average fat cell weight. Exercise test and determinatin f maximal xygen uptake (V02 max) A Mnark (Varberg, Sweden) mechanically braked bicycle ergmeter was used fr the exercise tests. The maximal xygen uptake measurements were perfrmed by stepwise wrk lad increase until exhaustin [9] with cntinuus ECG and frequent bld pressure recrdings. Expired air was cllected in Duglas bags, and the vlume and O2-cntent measured in a Beckman OM-I 1 instrument during the last minutes f the maximal wrk lad. The test was repeated nce at anther ccasin t ensure reprducibility, which was +3%. Heart rate and bld pressure at predetermined submaximal wrk lads (50 W and 100 W) were als recrded fr cmparisns befre and after the physical training prgramme. Physical training The grups were trained fr 3 mnths, three times a week. The duratin f each training sessin was 50min, starting with 10-15rain warm-up including walking, jgging and calisthenics f light intensity, and including exercises with all parts f the bdy. The prgramme then cntinued with alternating heavy and light perids. The heavy intervals were perfrmed n a bicycle ergmeter, lasted fr 4 min, and were standardized fr each patient t reach 80-90% f the individual VO2 max, cmmencing with a submaximal wrk lad. This level was adjusted upwards as the cnditining f the participants increased during the training t be kept at an 80-90% level. Euglycaemic glucse clamp measurements Arterial bld was drawn frm the radial artery and fed int an autmatic, cntinuus glucse mnitring system (Gambr, Lund, Sweden), which measures the bld glucse levels every minute. A slutin f 0.4 IU/ml f prcine insulin (Actrapid, Nv, Cpenhagen, Denmark) disslved in istnic saline was infused int the subclavian vein thrugh a catheter intrduced int a brachial vein with a cnstant infusin pump (IMED 922 H, San Dieg, Calif., USA). The insulin was given at tw infusin rates (0.08 and 0.60 IU. kg bdy weight -a. min-1). The plasma insulin levels btained by these infusins were nt different befre and after training ( and at lw level and and mu/1 at high level - means + SEM, befre and after training respectively). Bld glucse levels were kept cnstant by the infusin centrally f a 40% (w/v) slutin f glucse cntaining 100 mml/1 f ptassium, 20 mml/1 f magnesium and 30 mml/l f phsphate. Bld fr plasma insulin levels was drawn every 5 min. When steady state was reached, determined by the cefficients f variatin (mean + SD) fr insulin and glucse, the glucse dispsal rate was calculated during the last 20-rain perid f the lw and high insulin infusins respectively. The duratin f each f these perids was 60 min. These studies were perfrmed in a subgrup f 13 cntrl and 10 diabetic subjects wh gave their infrmed cnsent. Adipse tissue studies After fasting vernight, a subcutaneus adipse tissue bipsy was taken frm the hypgastric regin in lcal anaesthesia (Lidcaine, Astra, Sweden). Care was taken nt t infiltrate the tissue t be excised. Insulin binding Fat ceils were liberated by incubating the bipsies in medium 199 cntaining cltagenase (1.5 mg/ml) and 50 g/1 f bvine serum albumin

3 M. Krtkiewski et al.: Training in diabetes 883 Table 1. Characteristics f examined grups (Study I) Age (years) 37.1 _+ 1 Height (cm) Weight (kg) Whle bdy ptassium (Meq) Bdy fat (kg) Cntrl subjects Obese subjects (n=15) (n=55) Befre After training training _ _ (p<.l) 20.0_ _ _ <.l) Means _+ SEM. Cmparisns between cntrls and bese subjects Table 2. Characteristics f examined grups (Study II) Cntrl subjects (n = 13) Diabetic subjects (n = 33) Befre After Befre After Age (years) _ Bdyweight _ _+3.1 (kg) Bdy cell _ _ mass (kg) (p< 0.05) Bdyfat (kg) (p<0.05) Fat cell number (p < 0.05) (101~) Fat cell _ weight (p.g) Means_ SEM. Cmparisns between cntrls and Type 2 diabetic subjects fr 1 h at 37 ~ as previusly described [10]. After filtratin, the cells were carefully washed fur times in fresh medium. Insulin binding t the cells was then measured using the methd f Gamrneltft and Gliemann [11]. The cells were incubated fr 45rain at 24~ with ng/ml mncmpnent 125I-insulin. Cld insulin added was present at the indicated cncentratins. Tracer binding in the presence f 4.17ng/ml ( tU/ml) unlabelled insulin was cnsidered nnspecific and subtracted frm the results. Mean fat cell size was determined accrding t Smith et al. [10]. Mean fat cell surface area was calculated accrding t the frmula: SA= [d2+ SD 2] Jr: where SA= surface area, a = mean fat cell diameter, and SD the standard deviatin. Liplysis and glucse incrpratin int triglycerides After preincubating tissue fragments (average weight 10rag) fr 30 rain, the incubatins were perfrmed fr 2 h at 37 ~ in fresh medium 199 cntaining 1 mml glucse, 40g/1 bvine serum albumin, 0.t5 ~tci/ml (U-14C)-glucse and nradrenaline (10-5 M), and different cncentratins f insulin. Glycerl release t the incubatin medium, analyzed accrding t Laurell and Tibbling [12], was taken as an index f liplysis. Triglycerides were extracted accrding t Dle [13] and the radiactivity cunted. These studies were perfrmed in 12 cntrl and 18 diabetic subjects wh gave their infrmed cnsent. Glucagn-pr insulin was generusly supplied by Eli Lilly and C, (Indianaplis, Ind., USA). Medium 199 was btained frm Star- ens Bakterilgiska Labratrium, (Stckhlm, Sweden). Cllagenase, type I, bvine serum albumin, fractin V, and nrepinephrine bitartrate were frm Sigma (St.Luis, M., USA). U-14C-glucse (4 mci/mml) was btained frm New England Nuclear Crpratin (Bstn, Mass., USA), and ~2SI-mncmpnent insulin (specific activity abut 190 ~tci/ug) was a generus gift frm Dr. S. Ivarssn, Malmr, Sweden. Statistical methds Intra-individual differences, cmparing results befre and after the training perid as well as differences between grups, were tested using the Student's t-test. Results Study I As seen in Table 1, physical training was nt fllwed by any changes in bdy cmpsitin. All subjects fllwing the training prgramme shwed increases in VO2 max. and/r decreases f heart rate n a submaximal wrk lad (nt shwn). Table 3 shws that the fasting glucse values and sum f the glucse values during glucse tlerance test were higher in the grup f all bese subjects than in cntrls (p<0.05). The sum f insulin values during glucse tlerance test was als higher in the bese grup (p< 0.01) but the C-peptide values were nt. Physical training in the entire grup f bese subjects was nt fllwed by any changes in glucse r insulin, while the sum f C-peptide cncentratins decreased. Figure 1 a shws the C-peptide values befre and after physical training (r: 0.72 p< 0.01) and Figure 1 b the crrelatin between the changes in C-pepfide and the pretraining values (r: 0.28, p< 0.05). There were n crrelatins between the changes f insulin and glucse cncentratins with their respective pretraining values (nt shwn). T further analyse this phenmenn the bese subjects were divided int three grups with lw, nrmal r high insulin secretin, utilizing the sum f C-peptide values f the cntrls as dividing line. The bese subjects with C-peptide cncentratins within the mean _+ 2 SD f the cntrls were called nrmal insulin secretrs (NIS), thse belw r abve these limits were lw high insulin secretrs (LIS and HIS grups respectively). As seen in Table 3 these grups did nt differ in glucse tlerance, but the besity HIS grup had higher insulin values than the ther grups (p< 0.05). With physical training n changes ccurred in neither bld glucse nr insulin values in any f these grups. C-peptide values decreased in the HIS grup and NIS grup (nly sum f C-peptide values), and increased in the LIS grup (Table 3). There were n differences in bdy weight, bdy fat and ttal bdy ptassium between the grups and n changes with physical training (nt shwn).

4 884 M. Krtkiewski et al.: Training in diabetes Table 3. Effects f physical training n glucse tlerance and plasma insulin and C-peptide cncentratins (Study I) Cntrl subjects Obesity all Obesity HIS Obesity NIS Obesity LIS (n = 15) (n = 55) (n = 15) (n = 22) (n = 14) Fasting glucse (mml/1) Befre _+ 0.1 After _ p NS NS NS NS Sum f glucse (mml/1) Befre After p NS NS NS NS Fasting insulin (nml/l) Befre ' _ 0.01 After 0.11 _ _ _ p NS NS NS NS Sum f insulin (nml/1) Befre 1.00 :k _ _ After _ _ p - NS NS NS NS Fasting C-peptide (nml/1) Befre 0.32 _ After p NS 0.10 >p> 0.05 NS 0.10 >p> 0.05 Sum f C-peptide (nml/1) Befre 5.11 _ _ After p - p< 0.05 p< 0.05 p< 0.05 p< E lo c LD Z Z,< n," i-. n~ LU ~ E E Z -2 ua l, a. d LL O O ~ ~ ~ <3 -t, -6 SUM OF C-PEPTIDE a BEFORE TRAINING b ( nml / L ) -B Fig. 1. a The relatinship between the sum f plasma C-peptide cncentratins during glucse tlerance test befre and after physical training in bese subjects, y= x; r: 0.72; p< 0.01 (Study I). b The relatinship between the sum f plasma C-peptide cncentratins during glucse tlerance test befre training and the change in these values with physical training in bese subjects, y= x; r: 0.28; p < Shaded area: Mean_ 2 SD f values fr nnbese cntrls (Study I)

5 M. Krtkiewski et al.: Training in diabetes Study H Table 2 shws that age, bdy weight and average fat cell size did nt differ between the nn-diabetic and diabetic subjects. The diabetic subjects had higher bdy cell mass, less bdy fat and fewer fat cells than the nn-diabetic subjects. Nne f these variables changed with physical training. A mean increase was seen in maximal xygen uptake fllwing training, while heart rate and bld pressure decreased bth at rest and during submaximal wrk (Table 4). Examining individual data, five diabetic subjects did nt shw any evidence f physical training in neither VO2 max nr heart rate during submaximal Table 4. Circulatry variables f examined grups befre and after physical training (Study II) Cntrl subjects (n=13) Diabetic subjects (n=33) Befre After Befre After VO2 max b c (l/rain) Heart rate (beats/min) Rest a c Wrk 116 _ _ a (5 w) Wrk 147 _ _ _ b 4 b (1 v Systlic bld pressure (ram Hg) Rest _+4 ~ Wrk a (5v Wrk 179 _ _+6 ~ _+5 a (300 w) Means + SEM. Cmparisns between results befre and after physical training. ap<0.05; bp<0.01 Cp<0.001 wrk lad. These subjects were therefre excluded frm further analyses. The bld glucse levels were higher in the diabetic than the nn-diabetic subjects (Table 5). Plasma cncentratins f C-peptide as well as f insulin during OGTT were lwer in the diabetic grup. Plasma lipids were nt different. With physical training the plasma C-peptide cncentratins during the glucse tlerance test decreased in the nndiabetic subjects. In cntrast, in the diabetic grup, C-peptide cncentratins increased. Glucse intlerance imprved in the diabetic grup. Insulin r lipid values did nt change in any f the grups. Cmparisns between the diabetic subjects wh were treated with sulfnylurea r nt shwed higher glucse values and lwer C-peptide values in the frmer, but therwise n differences were fund. Bth shwed the same respnse t physical training. Furthermre, n difference in respnse t physical training was seen between men and wmen (nt shwn). Analgus t the nn-diabetic bese subjects in Study I the change in sum f C-peptide values during OGTT crrelated significantly with the C-peptide values befre cmmencing the training prgram as seen in Figure 2. It is als seen that this crrelatin was mainly due t an increase during physical training f lw values, particularly thse which befre training were belw the nrmal range. Here the average values increased dramatically frm 1.93 _ nml/1 befre training t 6.09 _ nml/1 after training (p< 0.001). There were n significant changes in insulin in this subgrup r in the remaining subjects. Euglycaemic glucse clamp studies The results f the euglycaemic glucse clamp studies are shwn in Fig. 3. The glucse dispsal rate was simi- 885 Table 5. Metablic variables f examined grups befre and after physical training (Study li) Cntrl subjects (n = 13) Diabetic subjects (n = 28) Befre After Befre After Fasting glucse _ (mml/l) (p< 0.001) Sum f glucse values during OGT]" a (mml/1) (p < 0.001) Fasting C-peptide _ (nml/l) (p < 0.05) Sum f C-peptide values during OGTF a J a (nml/1) (p< 0.01) Fasting insulin (nml/l) Sum f insulin values during OGTT 2.76 _ _ (nml/1) (t9< 0.01) Triglycerides _ (rnml/1) Chlesterl (mml/l) _+ 0.2 OGTF: Oral glucse tlerance test Means + SEM Cmparisns between cntrl and diabetic subjects (within parentheses) and between results befre and after physical training. a p< 0.05

6 886 M. Krtkiewski et al.: Training in diabetes lar in the diabetic and nn-diabetic grups at bth lw and high insulin infusin rates. Physical training increased the glucse dispsal rate in bth grups, and at bth insulin infusin rates. There was a psitive, significant crrelatin between imprvement in glucse tlerance (sum f glucse values during OGTI" befre - after) and the glucse dispsal rate (per kg LBM) in the glucse clamp studies in the diabetic grup (r: 0.65, p< 0.01). Adipse tissue studies Figure 4 depicts the data f insulin binding t adipcytes. There were n significant differences in insulin binding between the grups, neither befre nr after physical training. There was n change in binding after the training perid. Figure 5 shws the insulin effect n glucse incrpratin int triglycerides befre and after training. Adipcytes frm diabetic patients shwed less incrpratin than frm cntrls befre training (p< 0.05). The nn-diabetic grup shwed n change with training. In the diabetic grup, hwever, the insulin stimulated glucse incrpratin was significantly increased after physical training. Basal and nradrenaline-stimulated liplysis as well as the antiliplytic respnse f insulin, were similar in bth grups, and were nt significantly changed by the training perid. Insulin sensitivity, evaluated as the insulin cncentratin giving half-maximal antiliplytic effect, was als unchanged fllwing the training perid (data nt shwn). -d 4.0 E,,, ~+! 0.0 ~ -4.!, +t ~ SUM OF C-PEPrIDE ( nml/l ) Fig.2. The relatinship between the sum f plasma C-peptide cncentratins during glucse tlerance test befre training and the change in these values with physical training in patients with Type 2 diabetes, y= x; =0.35 ptb <0.01. Shaded area; Mean 2 SD f values fr nn-bese cntrls (Study II) 28-. "T 20- E _J E 12- /,. "T 20- LOW INSULIN INFUSION RATE HIGH INSULIN INFUSION RATE +_T_ --, ~k,._ L L,,/~ Discussin C-peptide and insulin are released frm the B cell in equimlar amunts [14, 15]. In cntrast t insulin, C- peptide is nt taken up by the liver in animals [16, 17] r in man [18, 19]. Measurements f C-peptide cncentratins in peripheral bld therefre give a better estimate f insulin secretin than measurements f peripheral insulin cncentratins. The validity f evaluating insulin secretin by C-peptide cncentratin measurements depends, hwever, n several additinal prerequisites. First, metablic clearance rate (MRC) has t be knwn t allw transfrmatins f cncentratin t actual secretin f insulin and C-peptide. If this is nt knwn, MCR has at least t be cnstant in different cnditins, and cmparable between different grups. MCR f C-peptide des nt change with stimulatin f insulin secretin. Uptake is apparently nt ccurring in muscle and adipse tissue, and the main excretry rute is via the kidneys [20]. Urinary clearance f C-peptide is essentially independent f the plasma C- peptide cncentratin, and similar in nrmal weight, bese and diabetic subjects in relatin t creatinine secretin [21, 22], and MCR f C-peptide is nt different > el Cntrl subjects Diabetic subjects Cntrt subjects Diabetic subjects Fig.3. Glucse dispsal rate in diabetic and cntrl subjects during euglycaemic clamp befre (hatched bars) and after (pen bars) physical training at tw different insulin infusin rates ( and mu/min, respectively). *p<0.05; **p<0.001; ***p< (Means_SEM) n=13 and n=10 fr cntrl and diabetic patients respectively (Study II) between nn-diabetic and diabetic subjects [23]. Taken tgether this infrmatin seems t make it pssible t cnclude that C-peptide secretin frm the B cell is equivalent t insulin secretin, and that liver uptake des nt invalidate estimatin f insulin secretin frm C-peptide determinatins. In summary, this means that the plasma C-peptide cncentratins in the present wrk prbably are useful indices f insulin secretin. The crrelatin between the decrease and initial value f C-peptide (Fig. 1 b) is partly a statistical artefact

7 M. Krtkiewski et al.: Training in diabetes ' 8 % ~ 0.I0 t-1 LI_ 0.05 B/F 0.05].'~, 10 t' IJ_ 0.05 B/F IOlL 0.05 I "~~s tb i I0 I()0 { Ib I()O a Insulin cncentratin b Insulin cncentratin ng/rn[ ng/m[ Fig.4a and b. Specific 125I-insulin binding t adipcytes in a diabetic and b cntrl subjects befre (pen circles) and after (filled circles) physical training. Inserted are shwn the Scatchard plts. Bund insulin expressed as ng/106 cells. (Means _ SEM) n= 12 and n= 17 fr cntrl and diabetic subjects, respectively (Study II) 15" Cntrl subjects Diabetic subjects (~O 0 Insulin cncentratin ~tu/m[ Fig.5. Basal and insulin stimulated UJ4C-glucse incrpratin int triglycerides in diabetic and cntrl subjects befre (hatched bars) and after (pen bars) physical training. * p < (Means + SEM). n=12 and n=18 fr cntrl and diabetic subjects, respectively (Study II) (regressin twards the mean) caused by the randm errrs (measurement errrs and intraindividual variatin). If the standard deviatin f the randm errrs were knwn it wuld be pssible t cmpute t what extent the bserved crrelatin is a bilgical reality. Lacking such precise infrmatin we can investigate whether the bserved crrelatin can pssibly be caused by the randm errrs alne. Such cmputatins shw that with the cefficient f variatin f the randm errrs equal t 10% the (false) crrelatin wuld be 0.03 and with a variatin f 20% the crrelatin wuld be A crrelatin cefficient 0.28 can thus hardly be an effect f regressin twards the mean. The bservatin must, hwever, be cnsidered as a rather weak indicatin f a bilgical relatinship since ne has als t take int accunt the sampling errrs in the crrelatin cefficient. The bserved value differs frm zer nly at the 5% significance level. These cnsideratins thus make it unlikely that the bserved crrelatin was explainable ther than t a minr degree by a statistical artefact. Therefre further analyses were perfrmed with the material f bese subjects divided int grups with nrmal, lw and high C-peptide values using cntrl values as guidance. Hyperinsulinaemia was fund in all the subgrups f besity (Table 3). Hypersecretin f insulin was, hwever, fund nly in the HIS grup, while in the LIS grup the insulin secretin was markedly lw. These findings indicate different causes t the hyperinsulinaemia in besity. One pssible explanatin might be fund in differences in the liver uptake f insulin. If this is the main explanatin the mlar ratis f insulin and C-peptide cncentratins in Table 3 suggest that very little f secreted insulin is taken up in the liver in the LIS grup, while the liver uptake in the NIS and HIS grups wuld be apprximately 60% and 70% respectively (sum f values). These bservatins cnfirm previus reprts [24, 25]. In the ttal grup f bese, nn-diabetic subjects (study I) physical training was fllwed by nly limited changes in the metablic and hrmnal variables. When divided int subgrups accrding t the initial insulin secretin, as indicated by C-peptide cncentratins, it was fund, hwever, that high and nrmal insulin secretrs shwed a decreased secretin after physical training. This was als the case with the bese cntrls in study II, wh were n an average high insulin secretrs with similar C-peptide values as the besity HIS grup in study I. This has been bserved repeatedly befre by measurements f insulin [4, 26, 27] and C- peptide [28]. In bese subjects with lw insulin secretin, hwever, physical training was fllwed by increased C-peptide values. Cnfirming previus studies [4, 28], n changes were seen in glucse tlerance r in bdy cmpsitin variables. Patients with diabetes mellitus imprved their glucse tlerance with physical training. This ccurred

8 888 M. Krtkiewski et al.: Training in diabetes withut changes in bdy cmpsitin and plasma insulin. C-peptide cncentratins increased, hwever. A clser analysis f this phenmenn revealed that this increase was mst prnunced in thse patients wh initially had the lwest C-peptide values, again indicating that physical training in this situatin actually causes an increase f a lw insulin secretin. Taken tgether these data then indicate that in cn- : ditins with insulin hypersecretin, physical training results in a decreased insulin secretin. In cntrast, in subjects with abnrmally lw insulin secretin this is elevated after physical training. Insulin hypersecretin is usually cnsidered t be the result f a cmpensatin fr an increased peripheral insulin resistance. When this resistance is lwered by physical training, as evidenced here by the glucse clamp studies, then cnsequently insulin secretin decreases. It is less clear why insulin secretin increases after physical training in cnditins with lw insulin secretin. It has previusly been shwn that physical training is fllwed by an increased sensitivity in bth the chlinergic [29] and B-adrenergic [30] nervus systems, bth stimulating insulin secretin. It is therefre suggested that this increased sensitivity is the cause t the increased insulin prductin after physical training in cnditins with lw insulin secretin reprted here. The changes in C-peptide cncentratins after physical training were much mre prnunced than thse in insulin. Neither when an elevated C-peptide cncentratin was lwered nr when C-peptide values were increased were insulin cncentratins in the periphery different after training as cmpared with befre. The unchanged peripheral insulin cncentratins in spite f alteratins in insulin secretin indicate that the uptake f insulin in the liver and/r periphery was altered. Insulin clearance did nt differ after as cmpared with befre training as measured with the glucse clamp technique (data nt shwn), indicating that changes in the remval f insulin in the periphery was nt changed by physical training. This in turn suggests that the uptake f insulin in the liver changed. In the case f an increased, lw insulin secretin this then prbably meant that the liver uptake f insulin had increased. This suggestin is supprted by the fact that insulin uptake in the liver is dependent n the prtal cncentratin f insulin [31], in turn dependent n insulin secretin. It seems reasnable t assume that this extra prductin f insulin after physical training, captured by the liver, cntributed t the imprvement f glucse intlerance seen in the diabetic subjects where the initial insulin secretin was subnrmal. Euglycaemic clamp studies The glucse dispsal rate estimated by the euglycaemic clamp shwed n difference between the grups with r withut diabetes mellitus, indicating a similar peripheral insulin effect n glucse uptake in these grups which bth were smewhat bese. The fact that the diabetic grup did nt appear resistant t insulin as cmpared t the nn-diabetic grup des nt mean that they were nrmal with regard t insulin sensitivity and respnsiveness. Rather insulin resistance was prbably equally present in bth grups. This was, hwever, imprved by physical training t a similar extent in bth grups. Frm ther studies it is knwn that insulin sensitivity is increased in muscles during cntractin [32, 33] r after physical training [34], while this des nt seem t be the case in the liver [34]. The effects f physical training seen in the glucse clamp studies were then presumably mainly due t an increase f glucse uptake in muscles [35]. Althugh an increase f peripheral effectiveness f insulin ccurred in bth grups, it was nly in the diabetic subjects that glucse tlerance imprved. The imprvement in glucse tlerance crrelated with the increase in glucse dispsal rate in the clamp measurement in the diabetic grup. Whether these phenmena are causally related remains t be clarified, but this seems at least t be a reasnable pssibility. Adipse tissue studies Adipse tissue nly plays a minr rle fr ttal bdy glucse hmestasis, as cmpared t muscles and liver [36]. Hwever, since insulin sensitivity and respnsiveness in fat cells seem t reflect the severity f glucse intlerance in diabetic subjects [37, 38], it may be f interest t cmpare data btained frm adipcytes in vitr with thse fund with the glucse clamp technique. Therefre, t further elucidate the cellular mechanisms explaining the higher rate f glucse dispsal fllwing physical training, studies n abdminal fat cells were perfrmed. Insulin binding has been fund nt t deviate frm nrmal in fat cells frm bese and Type 2 diabetic patients [37, 38]. The present study cnfirms these results. Furthermre, insulin binding was nt changed fllwing physical training in accrdance with previus reprts [39, 40]. In mncytes an increased binding has been fund [41, 42], but these cells are nt natural target cells fr insulin and, therefre, such data are less readily interpreted. Increased insulin binding t fat cells has been reprted after physical training in rats [43]. A recent study seems t reslve this cntrversy shwing that the increase in insulin binding, when fund after physical training, is f such small magnitude that it has n bvius physilgical significance in cmparisn with the increase in glucse transprt [44]. Differences in insulin binding are reflected by a shift f the dse-respnse curve fr insulin (altered insulin sensitivity) whereas a change in the maximal insulin effect (insulin respnsiveness) mirrrs pstreceptr defect(s) [45]. Accrdingly, insulin binding and insulin sensitivity, measured as the antiliplytic effect, were nt changed in this study. In cntrast, insulin respnsive-

9 M. Krtkiewski et al.: Training in diabetes 889 ness, as indicated by the maximal glucse incrpratin int triglycerides, was significantly imprved after physical training in the diabetic patients. Increased glucse transprt capacity has been fund previusly in fat cells frm trained rats [44]. The glucse clamp data indicate that physical training results in an increased insulin respnsiveness, because glucse dispsal rate was increased bth at the lw (submaximal) and the high (maximal) insulin infusin rates. Adipse tissue data then als shw that the effect f training n the insulin respnsiveness f glucse metablism is due t pstreceptr changes, and with n changes in insulin binding. These parallel findings suggest that, fllwing physical training, similar reactins are ccurring in ther tissues where glucse uptake is quantitatively mre significant than in adipse tissue. The insulin resistance in fat cells frm Type 2 diabetic subjects is mainly due t a diminished insulin respnsiveness f glucse metablism, prbably due t a pstreceptr-defect f glucse transprt [37, 38]. Hence, it is suggested that when physical training causes a reversal f this pstreceptr defect, an imprvement in glucse tlerance is btained. In cnclusin, this study has shwn that an imprvement f glucse tlerance is btained when mderately bese, diabetic subjects have been trained physically. Previus studies [1, 2] and studies appearing while this wrk was in prgress [47-49] have shwn varying results, which may be due t the fact that different subgrups f Type 2 diabetic patients react differently t physical training. The effect is prbably partly due t an increase f the insulin effectiveness n peripheral glucse uptake, presumably f main quantitative imprtance in muscles. This imprvement is accentuated by an increase f lw insulin secretin, prbably resulting in better insulinizatin f the liver. Taken tgether this then indicates that physical training imprves glucse tlerance by increasing insulin effects bth in the peripheral tissues (by increased tissue respnsiveness, due t a reversal f a pstreceptr defect), and in the liver (by uptake f an increased insulin secretin). Finally, it shuld be emphasized that the present study has shwn an imprvement f glucse tlerance by physical training in the absence f bdy cmpsitin changes. When bdy fat decreases in physical training prgrams, the effects n glucse tlerance and glucse hmestasis are prbably mre prnunced [46]. Acknwledgements. The statistical advice f N. Blmqvist, Ph.D., Department f Statistics, University f Grtebrg is gratefully acknwledged. This study was supprted by the Swedish Medical Research Cuncil (prject n. B 85-19X ), Nrdic Fundatin fr Research withut Animals, Greta and Einar Asker's Fundatin and Hjalmar Svenssn's Fundatin. References 1. Ruderman NB, Ganda OP, Jhansen K (1979) The effect f physical training n glucse tlerance and plasma lipids in maturity-nset diabetes. Diabetes 28 (Suppl 1): Saltin B, Lindg~irde F, Hustn M, Hrlin R, Nygaard E, Gad P (1979) Physical training and glucse tlerance in middle-aged men with chemical diabetes. Diabetes 28 (Suppl 1) Cstill DL, Cleary P, Fink WJ, Fster G, Ivy JL, Witzmann F (1979) Training adaptatins in skeletal muscle f juvenile diabetics. Diabetes 28: Bj6rntrp P, de Junge K, SjrstrOm L, Sullivan L (1970) The effect f physical training n insulin prductin in besity. Metablism 19: Natinal diabetes data grup. Natinal Institute f Health, Bethesda Maryland USA (1979) Classificatin and diagnse f diabetes mellitus and ther categries f glucse intlerance. Diabetes 2: SkrldbrnH, ArvidssnB, AnderssnM (1972) A new whle bdy mnitring labratry. Acta Radil 313 (Suppl): Frbes GB, Gallup J, Hurch JB (1961) Estimatin f ttal bdy fat frm ptassium-40 cntent. Science 133: SjrstrOm L, Bjrrntrp P, Vrana J (1971) Micrscpic fat cells size measurements n frzen-cut adipse tissue in cmparisn with autmatic determinatins f smium-fixed fat cells. J Lipid Res 12: ,~strand I (1960) Aerbic wrk capacity in men and wmen with special reference t age. Acta Physil Scand 49 (Suppl) Smith U, Sjrstr6m L, Bj6mtrp P (1972) Cmparisn f tw methds t determine human adipse cell size. J Lipid Res 13: GammeltftS, GliemannJ (1973) Binding and degradatin f 125-I-insulin by islated rat fat cells. Bichem Biphys Acta 320: Laurell S, Tibblin G (1966) An enzymatic flurimetric micrmethd fr the determinatin f glycerl. Clin Chim Acta 13: Dle VP, Meinerts H (1960) Micrdeterminatin f lng-chain fatty acids in plasma and tissue. J Bil Chem 235: Heding LG, Larsen OD, Markussen J, Jrgensen KH, Hallund O (1974) Radiimmunassays fr human, prk and f C-peptide and related substances. Hrm Metab Res 5 (Suppl): Hrwitz DL, Starr JI, Mak ME, BlackardWE, RubensteinAH (1975) Prinsulin, insulin and C-peptide cncentratins in human prtal and peripheral bld. J Clin Invest 55: Stll RW, TuberJL, Menahan LA, Williams RH (1970) Clearance f prcine insulin, prinsulin and cnnecting peptide by the islated rat liver. Prc Sc Exp Bil Med 111: Katz AI, Rubenstein AH (1973) Metablism f prinsulin, insulin and C-peptide in the rat. J Clin Invest 52: Canivet B, Krebs BP (1980) C-peptide uptake and excretin by the liver in man. Hrm Metab Res 12: Bratusch-Marain PR, Waldh~iusl WK, Gasic S, Hfer A (1984) Hepatic dispsal f bisynthetic human insulin and prcine C-peptide in humans. Metablism 33: Fiber OK, Kehlet H, Madsbad S, Binder C (1978) Kinetics f human C-peptide in man. Diabetes 27 (Suppl 1): Blix PM, Bddie-Willis C, Landau RL, Rchman H, Rubenstein AH (1982) Urinary C-peptide; an indicatr f beta-cell secretin under different metablic cnditins. J Clin Endcrinl Metab 54: Meistas MT, Rendell M, Marglis S, Kwarski AA (1982) Estimatin f the secretin rate f insulin frm the urinary excretin rate f C-peptide. Study in bese and diabetic subjects. Diabetes 31 : Faber OK, Hagen C, Binder C, Markussen J, Naithani VK, Blix PM, Kuzuya H, Hrwitz DL, Rubenstein AH, Rssing N (1978) Kinetics f human cnnecting peptide in nrmal and diabetic subjects. J Clin Invest 62: Rssell R, Gmis R, Casamitjana R, Segura E, Vilardell E, Rivera F (1983) Reduced hepatic insulin extractin in besity: relatinship with plasma insulin levels. J Clin Endcrinl Metab 56: Malmquist J, Lindg~irde F, Nrdrn G (1981) Plasma insulin and C-peptide in nrmal and glucse intlerant males: the rle f hepatic insulin uptake. Acta Med Scand 656: Bj6mtrp P, Fahlrn M, Grimby G, Gustafsn A, Hlm J, Renstrrm P, Scherst~n T (1972) Carbhydrate and lipid metab-

10 890 M. Krtkiewski et al.: Training in diabetes lism in middle-aged physically well-trained men. Metablism 1: Lhmann D, Liebld F, Heilmann W, Stenger J, Phl A (1978) Diminished insulin respnse in highly trained athletes. Metablism 27: Krtkiewski M, Bjtrntrp P, Hlm G, Marks V, Mrgan L, Smith U, Feurle GE (1984) Effects f physical training n insulin, cnnecting (c-peptide) gastric inhibitry plypeptide (GIP) and pancreatic plypeptide (PP) levels in bese subjects. Int J Obesity 8: Krtkiewski M, Sjtstrtm L, Bjtrntrp P (1980) Physical training in hyperplastic besity. V. Effects f atrpine n plasma insulin. Int J Obesity 4: Krtkiewski M, Mandrukas K, Mrgan L, William-Olssn T, Feurle GE, yn Schenk M, Bjtmtrp P, Sjtstrtm L, Smith U (1983) The effects f physical training n adrenergic sensitivity in besity. J Appl Physil 55: Karakash C, Assimacpuls-Jeannet F, Jeanrenaud B (1976) An anmaly f insulin remval in perfused livers f bese-hyperglycemic. (b/b) mice. J Clin Invest 57: Hllszy JO, Narahara HT (1965) Studies n tissue permeability X. Changes in permeability t 3-methylglucse assciated with cntractin f islated frg muscle. J Bil Chem 240: Berger M, Hagg S, Ruderman NB (1975) Glucse metablism in perfused skeletal muscle. Bichem J 146: MndnCE, Dlkas CB, Reaven GM (1980) Site f enchanged insulin sensitivity in exercise-trained rats at rest. Am J Physi1239: E169-E De Frnz RA, Tbin JD, Andres R (1979) Glucse clamp technique; a methd fr quantifying insulin secretin and resistance. Am J Physi1237:E214-E Bjtrntrp P, Berchtld P, Hlm J, LarssnB (1971) The glucse uptake f human adipse tissue in besity. Eur J Clin Invest 1 : Ltnnrth P, DiGirlam M, Krtkiewski M, Smith U (1983) Insulin binding and respnsiveness in fat cells frm patients with reduced glucse tlerance and type II diabetes. Diabetes 32: Kashiwagi A, Vers MA, Andrews J, Vasques B, Reaven G, Fley JE (1983) In vitr insulin resistance f human adipcytes islated frm subjects with nninsulin-dependent diabetes mellitus. J Clin Invest 72: Wirth A, Hlm G, Nilssn B, Smith U, Bjtrntrp P (1980) Insulin kinetics and insulin binding t adipcytes in physically trained and fdrestricted rats. Am J Physil 238:E105-E Wardzala L, Hrtn E, Jeanrenaud B (1980) Physical training increases glucse transprt and metablism in rat adipse cells withut altering insulin binding r sensitivity. Alim Nutr Metab 1 : 376 (Abstract) 41. Sman V, Kivist V, Diebert D, Felig P, de Frnz R (1979) Increased insulin sensitivity and insulin binding t mncytes after physical training. N Engl J Med 301: Kivist V, Sman V, Cnrad P, Hendler R, Nadel E, Felig P (1979) Insulin binding t mncytes in trained athletes. J Clin Invest 64: Craig BW, Hammns GT, Gartwaite SM, Jarett J, Hllszy JO (1981) Adaptatins f fat cells t exercise: respnse t glucse uptake and xidatin t insulin. J Appl Physil 51: Vinten H, Galb H (1983) Effect f physical training n transprt and metablism f glucse in adipcytes. Am J Physil E Kahn CR (1978) Insulin resistance, insulin intensitivity and insulin unrespnsiveness; a necessary distinctin. Metablism 27 (Suppl 2): BjOrntrp P, Berchtld P, Grimby G, Lindhlm B, Sanne H, Tibblin G, Wilhelmsen L (1972) Effects f physical training n glucse tlerance, plasma insulin and lipids and n bdy cmpsitin in men after mycardial infarctin. Acta Med Scand 192: Schneider SH, AmrsaLF. Khachadurian AK, Ruderman NB (1984) Studies n the mechanism f imprved glucse cntrl during regular exercise in Type 2 (nn-insulin-dependent) diabetes. Diabetlgia 26: Reitman JS, Vasquez B, Klimes I, Nagulesparan (1984) Imprvement f glucse hmestasis after exercise training in nn-insulindependent diabetes. Diabetes Care 7: Trvati M, Carla Q, Cavart F, Vitari S, Bnandi C, Lucchina PG, Ficchi F, Emanuelli G, Lenti G (1984) Influence f physical training n bld glucse cntrl, glucse tlerance, insulin secretin and insulin actin in nn-insulin-dependent diabetic patients. Diabetes Care 7: Received: 9 Octber 1984 and in revised frm: 30 September 1985 Dr. Per Bj6rntrp Department f Medicine I Sahlgrenska Sjukhuset S Gttebrg Sweden

by Springer-Verlag 1977

by Springer-Verlag 1977 Diabetlgia 13, 615-61 (177) Diabetlgia @ by Springer-Verlag 177 Prevalence f Residual B-Cell Functin in Insulin-Treated Diabetics Evaluated by the Plasma C-Peptide Respnse t Intravenus Giucagn C. Hendriksen,

More information

M.R.C.Path. causes to the raised plasma urea in patients admitted

M.R.C.Path. causes to the raised plasma urea in patients admitted Pstgradcuate Medical Jurnal (January 1979) 55, 1-14 The cause f the raised plasma urea f acute heart failure R D THOMAS MRCP D B MORGAN MRCPath ALISON NWILL AIMLS Departments f Cardilgy and Chemical Pathlgy,

More information

The estimator, X, is unbiased and, if one assumes that the variance of X7 is constant from week to week, then the variance of X7 is given by

The estimator, X, is unbiased and, if one assumes that the variance of X7 is constant from week to week, then the variance of X7 is given by ESTIMATION PROCEDURES USED TO PRODUCE WEEKLY FLU STATISTICS FROM THE HEALTH INTERVIEW SURVEY James T. Massey, Gail S. Pe, Walt R. Simmns Natinal Center fr Health Statistics. INTRODUCTION In April 97, the

More information

A Plasma Humoral Factor of Extrarenal Origin Causing Release of Reninlike Activity in Hypotensive Dogs

A Plasma Humoral Factor of Extrarenal Origin Causing Release of Reninlike Activity in Hypotensive Dogs A Plasma Humral Factr f Extrarenal Origin Causing Release f Reninlike Activity in Hyptensive Dgs By E. De Vit, C. Wilsn, R. E. Shipley, R. P. Miller, and B. L. Mrtx ABSTRACT Plasma reninlike activity significantly

More information

Obesity/Morbid Obesity/BMI

Obesity/Morbid Obesity/BMI Obesity/mrbid besity/bdy mass index (adult) Obesity/Mrbid Obesity/BMI Definitins and backgrund Diagnsis cde assignment is based n the prvider s clinical judgment and crrespnding medical recrd dcumentatin

More information

Swindon Joint Strategic Needs Assessment Bulletin

Swindon Joint Strategic Needs Assessment Bulletin Swindn Jint Strategic Needs Assessment Bulletin Swindn Diabetes 2017 Key Pints: This JSNA gives health facts abut peple with diabetes r peple wh might get diabetes in Swindn. This helps us t plan fr medical

More information

M.J. Guthriel, D.G. Wagner2

M.J. Guthriel, D.G. Wagner2 EFFECT OF SUPPLEMENTAL PROTEIN OR GRAIN ON INTAKE AND UTILIZATION OF MEDIUM QUALITY PRAIRIE HAY BY STEERS M.J. Guthriel, D.G. Wagner2 and D.C. Weakley3 Stry in Brief Sixteen 1,053 lb tw-year-ld Herefrd

More information

HEALTH SURVEILLANCE INDICATORS: CERVICAL CANCER SCREENING. Public Health Relevance. Highlights.

HEALTH SURVEILLANCE INDICATORS: CERVICAL CANCER SCREENING. Public Health Relevance. Highlights. HEALTH SURVEILLANCE INDICATORS: CERVICAL CANCER SCREENING Public Health Relevance Cervical cancer is 90% preventable by having regular Papaniclau (Pap) tests. The Pap test, als knwn as a cervical smear,

More information

Variation in Tissue Carnitine Concentrations with Age and Sex in the Rat

Variation in Tissue Carnitine Concentrations with Age and Sex in the Rat Bichem. J. (1978) 176, 677-681 Printed in Great Britain 677 Variatin in Tissue Carnitine Cncentratins with Age and Sex in the Rat By PEGGY R. BORUM Divisin fnutritin, Department fbichemistry, Vanderbilt

More information

DATA RELEASE: UPDATED PRELIMINARY ANALYSIS ON 2016 HEALTH & LIFESTYLE SURVEY ELECTRONIC CIGARETTE QUESTIONS

DATA RELEASE: UPDATED PRELIMINARY ANALYSIS ON 2016 HEALTH & LIFESTYLE SURVEY ELECTRONIC CIGARETTE QUESTIONS DATA RELEASE: UPDATED PRELIMINARY ANALYSIS ON 216 HEALTH & LIFESTYLE SURVEY ELECTRONIC CIGARETTE QUESTIONS This briefing has been specifically prepared fr the Ministry f Health t prvide infrmatin frm this

More information

Monensin and Extruded Urea-Grain for Range Beef Cows

Monensin and Extruded Urea-Grain for Range Beef Cows Mnensin and Extruded Urea-Grain fr Range Beef Cws R. P. Lemenager, F. N. Owens, w. E. Sharp, Merwin Cmptn and Rbert Ttusek Stry in Brief Tw trials were cnducted t evaluate the supplemental value f mnensin

More information

CDC Influenza Division Key Points MMWR Updates February 20, 2014

CDC Influenza Division Key Points MMWR Updates February 20, 2014 CDC Influenza Divisin Key Pints MMWR Updates In this dcument: Summary Key Messages Seasnal Influenza Vaccine Effectiveness: Interim Adjusted Estimates Influenza Surveillance Update: September 29, 2013-February

More information

Frequently Asked Questions: IS RT-Q-PCR Testing

Frequently Asked Questions: IS RT-Q-PCR Testing Questins 1. What is chrnic myelid leukemia (CML)? 2. Hw des smene knw if they have CML? 3. Hw is smene diagnsed with CML? Frequently Asked Questins: IS RT-Q-PCR Testing Answers CML is a cancer f the bld

More information

CONSENT FOR KYBELLA INJECTABLE FAT REDUCTION

CONSENT FOR KYBELLA INJECTABLE FAT REDUCTION CONSENT FOR KYBELLA INJECTABLE FAT REDUCTION INSTRUCTIONS This is an infrmed cnsent dcument which has been prepared t help yur Dctr infrm yu cncerning fat reductin with an injectable medicatin, its risks,

More information

The clinical trial information provided in this public disclosure synopsis is supplied for informational purposes only.

The clinical trial information provided in this public disclosure synopsis is supplied for informational purposes only. The clinical trial infrmatin prvided in this public disclsure synpsis is supplied fr infrmatinal purpses nly. Please nte that the results reprted in any single trial may nt reflect the verall ptential

More information

Cell Size and the Antilipolytic Effect of Insulin in Human Subcutaneous Adipose Tissue

Cell Size and the Antilipolytic Effect of Insulin in Human Subcutaneous Adipose Tissue Diabetlgia 11, 159-- 164 (1975) 9 by Springer-Verlag 1975 Cell Size and the Antiliplytic ffect f nsulin in Human Subcutaneus Adipse Tissue J. Ostman, L. Backman and D. Hallberg Dept. f Medicine, Huddinge

More information

1.11 INSULIN INFUSION PUMP MANAGEMENT INPATIENT

1.11 INSULIN INFUSION PUMP MANAGEMENT INPATIENT WOMEN AND NEWBORN HEALTH SERVICE CLINICAL GUIDELINES SECTION A: GUIDELINES RELEVANT TO OBSTETRICS AND GYNAECOLOGY 1 STANDARD PROTOCOLS 1.11 INSULIN INFUSION PUMP MANAGEMENT - INPATIENT Authrised by: OGCCU

More information

NFS284 Lecture 3. How much of a nutrient is required to maintain health? Types and amounts of foods to maintain health

NFS284 Lecture 3. How much of a nutrient is required to maintain health? Types and amounts of foods to maintain health NFS284 Lecture 3 Chapter 2: Nutritin: Guidelines: Applying the Science f Nutritin 2.1 Nutritin Recmmendatin fr the Canadian Diet Nutrient-based apprach Hw much f a nutrient is required t maintain health?

More information

Chapter 6: Impact Indicators

Chapter 6: Impact Indicators Overview Chapter 6: Impact Indicatrs The best measure f the lng-term impact f all HIV preventin activities is the HIV incidence rate, namely the number f new cases f HIV infectin per year divided by the

More information

Breast Cancer Awareness Month 2018 Key Messages (as of June 6, 2018)

Breast Cancer Awareness Month 2018 Key Messages (as of June 6, 2018) Breast Cancer Awareness Mnth 2018 Key Messages (as f June 6, 2018) In this dcument there are tw sectins f messages in supprt f Cancer Care Ontari s Breast Cancer Awareness Mnth 2018: 1. Campaign key messages

More information

Bariatric Surgery FAQs for Employees in the GRMC Group Health Plan

Bariatric Surgery FAQs for Employees in the GRMC Group Health Plan Bariatric Surgery FAQs fr Emplyees in the GRMC Grup Health Plan Gergia Regents Medical Center and Gergia Regents Medical Assciates emplyees and eligible dependents wh are in the GRMC Grup Health Plan (Select

More information

Effect of opioid blockade on insulin metabolism in polycystic ovarian disease

Effect of opioid blockade on insulin metabolism in polycystic ovarian disease Human Reprductin vl.10 n.9 pp.2253-2257, 1995 Effect f piid blckade n insulin metablism in plycystic varian disease A.M.Fulghesu, M.Ciampelli, A.Frtini, F.Cucinelli, M.Guid, A.Carus, A.Lanzne 1 and S.Mancus

More information

Diabetologia 9 Springer-Verlag 1985

Diabetologia 9 Springer-Verlag 1985 Diabetlgia (1985) 28:330-334 Diabetlgia 9 Springer-Verlag 1985 The influence f insulin antibdy levels n the plasma prfiles and actin f subcutaneusly injected human and bvine shrt acting insulins A. J.

More information

Diabetologia 9 Springer-Verlag 1982

Diabetologia 9 Springer-Verlag 1982 Diabetlgia (1982) 23:313-319 Diabetlgia 9 Springer-Verlag 1982 Originals Hepatic and Peripheral Insulin Resistance: A Cmmn Feature f ype 2 (Nn-Insulin-Dependent) and ype 1 (Insulin-Dependent) Diabetes

More information

Insulin Secretory Response of Diabetics during the Period of Improvement of Glucose Tolerance to Normal Range

Insulin Secretory Response of Diabetics during the Period of Improvement of Glucose Tolerance to Normal Range Diabetlgia 10, 775--782 (1974) 9 by Springer-Verlag 1974 Insulin Secretry Respnse f Diabetics during the Perid f Imprvement f Glucse Tlerance t Nrmal Range K. Ksaka 1, R. Hagura 2, T. Kuzuya 3, and N.

More information

Diabetologia. Response of adipose tissue lipoprotein lipase activity and serum lipoproteins to acute hyperinsulinaemia in man.

Diabetologia. Response of adipose tissue lipoprotein lipase activity and serum lipoproteins to acute hyperinsulinaemia in man. Diabetlgia (1984) 364-369 Diabetlgia 9 Springer-Verlag 1984 Respnse f adipse tissue lipprtein lipase activity and serum lipprteins t acute hyperinsulinaemia in man H. Yki-J~irvinen, M.-R. Taskinen, V.

More information

Diabetologia 9 by Springer-Verlag 1979

Diabetologia 9 by Springer-Verlag 1979 Diabetlgia 16, 365-372 (1979) Diabetlgia 9 by Springer-Verlag 1979 Interrelatinships f Glucse and Insulin Uptake by Muscle f Nrmal and Diabetic Man vidence f a Difference in Metablism f ndgenus and xgenus

More information

ALCAT FREQUENTLY ASKED QUESTIONS

ALCAT FREQUENTLY ASKED QUESTIONS 1. Is fasting required befre taking the Alcat Test? N. It is recmmended t drink water and t avid stimulants like caffeine prir t the test. 2. With regard t testing children, must a child be a certain age

More information

Imaging tests allow the cancer care team to check for cancer and other problems inside the body.

Imaging tests allow the cancer care team to check for cancer and other problems inside the body. IMAGING TESTS This infrmatin may help answer sme f yur questins and help yu think f ther questins that yu may want t ask yur cancer care team; it is nt intended t replace advice r discussin between yu

More information

DIRECTED FORGETIING: SHORT-TERM MEMORY OR CONDITIONED RESPONSE? WENDY S. MILLER and HARVARD L. ARMUS The University of Toledo

DIRECTED FORGETIING: SHORT-TERM MEMORY OR CONDITIONED RESPONSE? WENDY S. MILLER and HARVARD L. ARMUS The University of Toledo The Psychlgical Recrd, 1999, 49, 211-220 DIRECTED FORGETIING: SHORT-TERM MEMORY OR CONDITIONED RESPONSE? WENDY S. MILLER and HARVARD L. ARMUS The University f Tled Previus researchers have interpreted

More information

Completing the NPA online Patient Safety Incident Report form: 2016

Completing the NPA online Patient Safety Incident Report form: 2016 Cmpleting the NPA nline Patient Safety Incident Reprt frm: 2016 The infrmatin cntained within this dcument is in line with the current Data Prtectin Act (DPA) requirements. This infrmatin may be subject

More information

Programme of Learning. Physical Education. Key Stage 4 Year 10 BTEC Sport

Programme of Learning. Physical Education. Key Stage 4 Year 10 BTEC Sport Prgramme f Learning Physical Educatin Key Stage 4 Year 10 BTEC Sprt BTEC Sprt Level 2 Unit 1Fitness fr Sprt and Exercise... 2 Learning aim A: Knw abut the cmpnents f fitness and the principles f training...

More information

Diabetologia 9 Springer-Verlag 1992

Diabetologia 9 Springer-Verlag 1992 Diabetlgia (1992) 35:121-128 Diabetlgia 9 Springer-Verlag 1992 The influence f human C-peptide n renal functin and glucse utilizatin in Type 1 (insulin-dependent) diabetic patients B.-L. Jhanssn 1' 3,

More information

Cnsideratin fr Optimizatin: Optimizatin is a prgram transfrmatin technique, which tries t imprve the cde by making it cnsume fewer resurces (i.e. CPU, Memry) and deliver high speed. In ptimizatin, high-level

More information

potassium status of patients with heart failure

potassium status of patients with heart failure Pstgraduate Medical Jurnal (June 1978) 54, 45-49. The effects f ptassium supplements, spirnlactne r amilride n the ptassium status f patients with heart failure C. DAVIDSON M.A., M.B., M.R.C.P. D. B. MORGAN

More information

CONTACT: Amber Hamilton TYPE 2 DIABETES AND OBESITY: TWIN EPIDEMICS OVERVIEW

CONTACT: Amber Hamilton TYPE 2 DIABETES AND OBESITY: TWIN EPIDEMICS OVERVIEW FACT SHEET CONTACT: Amber Hamiltn 212-266-0062 TYPE 2 DIABETES AND OBESITY: TWIN EPIDEMICS OVERVIEW Type 2 diabetes accunts fr 90-95% f the 29.1 millin diabetes cases in the U.S. 1 Obesity is a majr independent

More information

Springer-Verlag 1991

Springer-Verlag 1991 Diabetlgia (1991) 34:801-806 Diabetlgia @ Springer-Verlag 1991 Abnrmal glucagn respnse t arginine and its nrmalizatin in bese hyperinsulinaemic patients with glucse intlerance: imprtance f insulin actin

More information

Diabetologia 9 Springer-Verlag 1991

Diabetologia 9 Springer-Verlag 1991 Diabetlgia (1991) 34:23%245 0012186X91000594 Diabetlgia 9 Springer-Verlag 1991 Reduced glycgen synthase activity in skeletal muscle frm bese patients with and withut Type 2 (nn-insulin-dependent) diabetes

More information

Diabetologia 9 Springer-Verlag 1989

Diabetologia 9 Springer-Verlag 1989 Diabetlgia (1989) 32:28-33 Diabetlgia 9 Springer-Verlag 1989 Determinatin and kinetic analysis f nn-insulin mediated glucse uptake in Type 1 (insulin-dependent) diabetes mellitus S. L. Shumak, M. Gulan,

More information

Human papillomavirus (HPV) refers to a group of more than 150 related viruses.

Human papillomavirus (HPV) refers to a group of more than 150 related viruses. HUMAN PAPILLOMAVIRUS This infrmatin may help answer sme f yur questins and help yu think f ther questins that yu may want t ask yur cancer care team; it is nt intended t replace advice r discussin between

More information

Reference: Patient A. Brenda WXXXXX Date of Birth: 4/15/57

Reference: Patient A. Brenda WXXXXX Date of Birth: 4/15/57 Reference: Patient A Brenda WXXXXX Date f Birth: 4/15/57 49 year ld white female patient presented n July 20, 2006 with chief cmplaint f stage 4 cancer, initially diagnsed in Octber, 2003 with Cervical

More information

INVESTIGATIVE OPHTHALMOLOGY. Dexamethasone testing in Southwestern Indians

INVESTIGATIVE OPHTHALMOLOGY. Dexamethasone testing in Southwestern Indians May 1970 Vlume 9, Number 5 INVESTIGATIVE OPHTHALMOLOGY Dexamethasne testing in Suthwestern Luis J. Rsenbaum, Ellen Altn, and Bernard Becker f the Suthwestern United States demnstrated prevalences f primary

More information

Annex III. Amendments to relevant sections of the Product Information

Annex III. Amendments to relevant sections of the Product Information Changes t the Prduct infrmatin as apprved by the CHMP n 13 Octber 2016, pending endrsement by the Eurpean Cmmissin Annex III Amendments t relevant sectins f the Prduct Infrmatin Nte: These amendments t

More information

TREATMENT OF POLYCYTHEMIA VERA

TREATMENT OF POLYCYTHEMIA VERA RUSSELL L. HADEN, M.D. Plycythemia vera is characterized by an increase in the number f red bld cells. This disease is insidius in rigin, chrnic, and withut pathgnmnic symptms r physical findings. Early

More information

Temporal Relationship of Glycosylated Haemoglobin Concentrations to Glucose Control in Diabetics

Temporal Relationship of Glycosylated Haemoglobin Concentrations to Glucose Control in Diabetics Diabetlgia 17, 213-22 (1979) Diabetlgia 9 by Springer-Verlag 1979 Originals Tempral Relatinship f Glycsylated Haemglbin Cncentratins t Glucse Cntrl in Diabetics P. J. Dunn, R. A. Cle, J. S. Seldner, R.

More information

Risk factors in health and disease

Risk factors in health and disease Risk factrs in health and disease Index 1 Intrductin 2 Types f risk factrs 2.1 Behaviural risk factrs 2.2 Psychlgical risk factrs 2.3 Demgraphic risk factrs 2.4 Envirnmental risk factrs 2.5 Genetic risk

More information

CDC Influenza Technical Key Points February 15, 2018

CDC Influenza Technical Key Points February 15, 2018 CDC Influenza Technical Key Pints In this dcument: Summary Key Pints U.S. Vaccine Effectiveness U.S. Flu Activity Update Summary Key Pints On Thursday, tw influenza-related reprts appeared in the Mrbidity

More information

PROTOCOL 1850 Millrace Drive, Suite 3A Eugene, Oregon

PROTOCOL 1850 Millrace Drive, Suite 3A Eugene, Oregon PROTOCOL Cmplex II Enzyme Activity Micrplate Assay Kit 1850 Millrace Drive, Suite 3A Eugene, Oregn 97403 MS241 Rev.0 DESCRIPTION Cmplex II Enzyme Activity Micrplate Assay Kit Sufficient materials are prvided

More information

Cardiac Rehabilitation Services

Cardiac Rehabilitation Services Dcumentatin Guidance N. DG1011 Cardiac Rehabilitatin Services Revisin Letter A 1.0 Purpse The Centers fr Medicare and Medicaid Services (CMS) has detailed specific dcumentatin requirements fr Cardiac Rehabilitatin

More information

Data Fusion for Predicting Breast Cancer Survival

Data Fusion for Predicting Breast Cancer Survival Data Fusin fr Predicting Breast Cancer Linbailu Jiang, Yufei Zhang, Siyi Peng Mentr: Irene Kaplw December 11, 2015 1 Intrductin 1.1 Backgrund Cancer is mre f a severe health issue than ever in ur current

More information

The demonstration of lysosomes by the controlled temperature freezing-sectioning method By LUCILLE BITENSKY

The demonstration of lysosomes by the controlled temperature freezing-sectioning method By LUCILLE BITENSKY 205 The demnstratin f lyssmes by the cntrlled temperature freezing-sectining methd By LUCILLE BITESKY (Frm the Department f Pathlgy, Ryal Cllege f Surgens f England, Lincln's Inn Fields, Lndn, W.C. 2)

More information

Field Epidemiology Training Program

Field Epidemiology Training Program Field Epidemilgy Training Prgram Cancer Curriculum: Principles f Cancer Registries Case Study: Hspital-Based Cancer Registries FACILITATOR GUIDE FETP Cancer Curriculum: Principles f Cancer Registries Case

More information

Commissioning Policy: South Warwickshire CCG (SWCCG)

Commissioning Policy: South Warwickshire CCG (SWCCG) Cmmissining Plicy: Suth Warwickshire CCG (SWCCG) Treatment Indicatin Criteria FreeStyle Libre Flash Cntinuus Glucse Mnitring System Type I Diabetes Prir apprval must be requested frm the Individual Funding

More information

detailed in Ward and Lockhead (1970), is only summarized here.

detailed in Ward and Lockhead (1970), is only summarized here. Respnse system prcesses in abslute judgment* LAWRENCE M. WARDt and G. R. LOCKHEAD Duke University, Durham, Nrth Carlina 2778 Cnsistent relatinships are fund between Ss' abslute judgments f the value f

More information

Nutrition Care Process Model Tutorials. Nutrition Monitoring & Evaluation: Overview & Definition. By the end of this module, the participant will:

Nutrition Care Process Model Tutorials. Nutrition Monitoring & Evaluation: Overview & Definition. By the end of this module, the participant will: Nutritin Care Prcess Mdel Tutrials Nutritin Care Prcess and Terminlgy Cmmittee Academy f Nutritin and Dietetics Nutritin Care Prcess Terminlgy 2015 Editin Nutritin Mnitring & Evaluatin: Overview & Definitin

More information

Intravenous Vancomycin Use in Adults Intermittent (Pulsed) Infusion

Intravenous Vancomycin Use in Adults Intermittent (Pulsed) Infusion Backgrund This plicy cvers the use f intravenus vancmycin prescribed as an intermittent (pulsed) infusin. This can be used fr treatment r prphylaxis. Evidence supprting this guidance is detailed belw.

More information

VITAPRO. Detoxification properties of Apple pectin formulation, PROPECTIN. CENTRE D ETUDE ET DE VALORISATION DES ALGUES FINAL REPORT.

VITAPRO. Detoxification properties of Apple pectin formulation, PROPECTIN. CENTRE D ETUDE ET DE VALORISATION DES ALGUES FINAL REPORT. CENTRE D ETUDE & DE VALORISATION DES ALGUES 2400 Detxificatin prperties f Apple pectin frmulatin, PROPECTIN. VITAPRO FINAL REPORT PrPectin July 2015 CENTRE D ETUDE ET DE VALORISATION DES ALGUES PRESQU

More information

Osteoporosis Fast Facts

Osteoporosis Fast Facts Osteprsis Fast Facts Fast Facts n Osteprsis Definitin Osteprsis, r prus bne, is a disease characterized by lw bne mass and structural deteriratin f bne tissue, leading t bne fragility and an increased

More information

Printed copies of this document may not be up to date, obtain the most recent version from Author Position

Printed copies of this document may not be up to date, obtain the most recent version from   Author Position Printed cpies f this dcument may nt be up t date, btain the mst recent versin frm www.cats.nhs.uk Children s Acute Transprt Service Clinical Guidelines Diabetic Ketacidsis Dcument Cntrl Infrmatin Authr

More information

Intravenous Vancomycin Use in Adults Intermittent (Pulsed) Infusion

Intravenous Vancomycin Use in Adults Intermittent (Pulsed) Infusion Intravenus Vancmycin Use in Adults Intermittent (Pulsed) Infusin Backgrund This plicy cvers the use f intravenus vancmycin prescribed as an intermittent (pulsed) infusin. This can be used fr treatment

More information

Topic 12: Endocrine System. Function: Group of glands that produces regulatory chemicals ( )

Topic 12: Endocrine System. Function: Group of glands that produces regulatory chemicals ( ) Tpic 12: Endcrine System Functin: Grup f glands that prduces regulatry chemicals ( ) Hrmnes: Chemical messengers released directly int the bldstream that regulate: *May have wide-spread effects r nly affect

More information

A pre-conference should include the following: an introduction, a discussion based on the review of lesson materials, and a summary of next steps.

A pre-conference should include the following: an introduction, a discussion based on the review of lesson materials, and a summary of next steps. NAU Mdel Observatin Prtcl The mdel prtcl was develped with supprt and expertise frm the Natinal Institute fr Excellence in Teaching (NIET) and is based in great part n NIET s extensive experience cnducting

More information

Autonomic. Nervous System

Autonomic. Nervous System Autnmic Nervus System Cmpiled by Campbell M Gld (2006) CMG Archives http://campbellmgld.cm IMPORTANT The health infrmatin cntained herein is nt meant as a substitute fr advice frm yur physician, r ther

More information

Related Policies None

Related Policies None Medical Plicy MP 3.01.501 Guidelines fr Cverage f Mental and Behaviral Health Services Last Review: 8/30/2017 Effective Date: 8/30/2017 Sectin: Mental Health End Date: 08/19/2018 Related Plicies Nne DISCLAIMER

More information

Diabetologia 9 Springer-Verlag 1995

Diabetologia 9 Springer-Verlag 1995 Diabetlgia (1995) 38:565-572 Diabetlgia 9 Springer-Verlag 1995 nsulin resistance and hyperinsulinaemia in mild t mderate prgressive chrnic renal failure and its assciatin with aerbic wrk capacity. idemak

More information

Obesity and Insulin Resistance: Effect of Race and Gender

Obesity and Insulin Resistance: Effect of Race and Gender Relatin fthe White Bld Cell Cunt t Obesity and Insulin Resistance: Effect f Race and Gender Richard E. Pratley, Charltn Wilsn*, Cliftn Bgardus Abstract PRATLEY, RICHARD E, CHARLTON WILSON AND CLIFTON BOGARDUS.

More information

SUMMACARE COMMERCIAL MEDICATION REQUEST GUIDELINES. ANTI-OBESITY AGENTS Generic Brand HICL GCN Exception/Other QSYMIA 32515, 32744, 32746, 32745

SUMMACARE COMMERCIAL MEDICATION REQUEST GUIDELINES. ANTI-OBESITY AGENTS Generic Brand HICL GCN Exception/Other QSYMIA 32515, 32744, 32746, 32745 Generic Brand HICL GCN Exceptin/Other NALTREXONE CONTRAVE ER 41389 /BUPROPION LORCASERIN BELVIQ 34733 PHENTERMINE PHENTERMINE 20691 20692 20693 20713 PHENTERMINE LOMAIRA 20715 PHENTERMINE/TO PIRAMATE GUIDELINES

More information

FOUNDATIONS OF DECISION-MAKING...

FOUNDATIONS OF DECISION-MAKING... Table f Cntents FOUNDATIONS OF DECISION-MAKING... Errr! Bkmark nt Describe the decisin-making prcess pp.62-66... Errr! Bkmark nt Explain the three appraches managers can use t make decisins pp.67-70 Errr!

More information

Diabetologia 9 Springer-Verlag 1989

Diabetologia 9 Springer-Verlag 1989 Diabetlgia (1989) 32: 305-311 Diabetlgia 9 Springer-Verlag 1989 Fasting plasma C-peptide, glucagn stimulated plasma C-peptide, and urinary C-peptide in relatin t clinical type f diabetes H. J. Gjessing

More information

Urinary Kallikrein in Rats Bred for Their Susceptibility and Resistance to the Hypertensive Effect of Salt

Urinary Kallikrein in Rats Bred for Their Susceptibility and Resistance to the Hypertensive Effect of Salt 727 Urinary in Rats Bred fr Their Susceptibility and Resistance t the Hypertensive Effect f Salt A New Radiimmunassay fr Its Direct Determinatin OSCAR A. CARRETERO, VASUDEV M. AMIN, TERESA OCHOLIK, ALFONSO

More information

School Medication Authorization Form. School Grade Teacher. Emergency Phone No: To be completed by the student's physician: Name of Medication:

School Medication Authorization Form. School Grade Teacher. Emergency Phone No: To be completed by the student's physician: Name of Medication: Schl Medicatin Authrizatin Frm Student's Name Address Birth Date Hme Phne Schl Grade Teacher Emergency Phne N: T be cmpleted by the student's physician: Name f Medicatin: Dsage Frequency Time t be given

More information

Diabetologia 9 by Springer-Verlag 1977

Diabetologia 9 by Springer-Verlag 1977 Diabetlgia 13, 35-41 (1977) Diabetlgia 9 by Springer-Verlag 1977 Is a Lag-Strage Curve an Early Sign f Diabetes? Early Insulin Respnses t i.v. Glucse in Nrmal Subjects, Mild Maturity-Onset Diabetics and

More information

Health Screening Record: Entry Level Due: August 1st MWF 150 Entry Year

Health Screening Record: Entry Level Due: August 1st MWF 150 Entry Year Health Screening Recrd: Entry Level MIDWIFERY EDUCATION PROGRAM HEALTH SCREENING REQUIREMENTS (Rev. June 2017) 1. Hepatitis B: Primary vaccinatin series (3 vaccines 0, 1 and 6 mnths apart), plus serlgic

More information

Patterns of Cholesterol Distribution in the Participants of a Screening Project

Patterns of Cholesterol Distribution in the Participants of a Screening Project Patterns f Chlesterl Distributin in the Participants f a Screening Prject Abdul Hamid Shaikh, S With guidelines similar t thse recmmended by the Natinal Chlesterl Educatin Prgram (NCEP), 3,3 individuals

More information

Significance of Chronic Kidney Disease in 2015

Significance of Chronic Kidney Disease in 2015 1 Significance f Chrnic Kidney Disease in 2015 There is still a requirement within QOF t keep a register f peple with CKD stages 3-5. The ther CKD QOF targets have been retired. This is because CKD care

More information

EXPLORING THE PROCESS OF ASSESSMENT AND OTHER RELATED CONCEPTS

EXPLORING THE PROCESS OF ASSESSMENT AND OTHER RELATED CONCEPTS 1 SECTION 1 INTRODUCTION: EXPLORING THE PROCESS OF ASSESSMENT AND OTHER RELATED CONCEPTS The Nature Of Assessment The Definitin Of Assessment The Difference Between Testing, Measurement And Evaluatin Characteristics

More information

CONDITIONS characterized by the presence

CONDITIONS characterized by the presence Cardiac Functin in Experimental Mitral Stensis By F..1. HADDY, M.D., A. L. FERRIN, M.D., D. W. HANNON, M.D., J. F. ALDEN, M.D., W. L. ADAMS, M.D., AND I. D. BARONOFSKY, M.D., PH.D. The results f S5 cmbined

More information

Adult Preventive Care Guidelines

Adult Preventive Care Guidelines Adult Preventive Care Guidelines Gundersen is yur partner fr better health. We want t wrk with yu t make sure that yu and yur family are as healthy as pssible. That can be accmplished best if we wrk tgether

More information

Safety of HPV vaccination: A FIGO STATEMENT

Safety of HPV vaccination: A FIGO STATEMENT FIGO Statement n HPV Vaccinatin Safety, August 2nd, 2013 Safety f HPV vaccinatin: A FIGO STATEMENT July, 2013 Human papillmavirus vaccines are used in many cuntries; glbally, mre than 175 millin dses have

More information

Diabetologia. Glomerular Size and Structure in Diabetes Mellitus. II. Late Abnormalities. Diabetologia 13, (1977) 9 by Springer-Verlag 1977

Diabetologia. Glomerular Size and Structure in Diabetes Mellitus. II. Late Abnormalities. Diabetologia 13, (1977) 9 by Springer-Verlag 1977 Diabetlgia 13, 43-48 (1977) Diabetlgia 9 by Springer-Verlag 1977 Glmerular Size and Structure in Diabetes Mellitus. II. Late Abnrmalities H. J. G. Gundersen and R. r Secnd University Clinic f Internal

More information

2018 Medical Association Poster Symposium Guidelines

2018 Medical Association Poster Symposium Guidelines 2018 Medical Assciatin Pster Sympsium Guidelines Overview The 3 rd Annual student-run Medical Assciatin f the State f Alabama Research Sympsium will take place n Friday and Saturday, April 13-14 at the

More information

Diabetologia 9 Springer-Verlag 1994

Diabetologia 9 Springer-Verlag 1994 Diabetlgia (1994) 37:826-832 Diabetlgia 9 Springer-Verlag 1994 Effect f metfrmin n insulin-stimulated glucse transprt in islated skeletal muscle btained frm patients with NIDDM D. Galuska, L. A. Nlte,

More information

Appendix C Guidelines for treating status epilepticus in adults and children

Appendix C Guidelines for treating status epilepticus in adults and children Appendix C Guidelines fr treating status epilepticus in adults and children 1.1 Treating cnvulsive status epilepticus in adults General measures 1st stage (0 10 minutes) Secure airway and resuscitate Administer

More information

Continuous Positive Airway Pressure (CPAP) and Respiratory Assist Devices (RADs) including Bi-Level PAP

Continuous Positive Airway Pressure (CPAP) and Respiratory Assist Devices (RADs) including Bi-Level PAP Cntinuus Psitive Airway Pressure (CPAP) and Respiratry Assist Devices (RADs), Including Bi-Level PAP Benefit Criteria t Change fr Texas Medicaid Effective March 1, 2017 Overview f Benefit Changes Benefit

More information

Diabetologia 9 Springer-Verlag 1989

Diabetologia 9 Springer-Verlag 1989 Diabetlgia (1989) 32: 599-605 Diabetlgia 9 Springer-Verlag 1989 Different effects f insulin and ral antidiabetic agents n glucse and energy metablism in Type 2 (nn-insulin-dependent) diabetes mellitus

More information

A Phase I Study of CEP-701 in Patients with Refractory Neuroblastoma NANT (01-03) A New Approaches to Neuroblastoma Therapy (NANT) treatment protocol.

A Phase I Study of CEP-701 in Patients with Refractory Neuroblastoma NANT (01-03) A New Approaches to Neuroblastoma Therapy (NANT) treatment protocol. SAMPLE INFORMED CONSENT A Phase I Study f CEP-701 in Patients with Refractry Neurblastma NANT (01-03) A New Appraches t Neurblastma Therapy (NANT) treatment prtcl. The wrd yu used thrughut this dcument

More information

FDA Dietary Supplement cgmp

FDA Dietary Supplement cgmp FDA Dietary Supplement cgmp FEBRUARY 2009 OVERVIEW Summary The Fd and Drug Administratin (FDA) has issued a final rule regarding current gd manufacturing practices (cgmp) fr dietary supplements that establishes

More information

Insulin-Mediated Increases in the HDL Cholesterol/Cholesterol Ratio in Humans

Insulin-Mediated Increases in the HDL Cholesterol/Cholesterol Ratio in Humans Insulin-Mediated Increases in the HDL Chlesterl/Chlesterl Rati in Humans Craig N. Sadur and Rbert H. Eckel The rle f insulin in the regulatin f lipprtein chlesterl distributin was studied in 18 human vlunteers

More information

University College Hospital. Pump school Starting on an insulin pump. Children and Young People s Diabetes Service

University College Hospital. Pump school Starting on an insulin pump. Children and Young People s Diabetes Service University Cllege Hspital Pump schl Starting n an insulin pump Children and Yung Peple s Diabetes Service 2 If yu wuld like this dcument in anther language r frmat, r require the services f an interpreter,

More information

The Excretory System. 4 The Excretory System.notebook. May 24, 2017

The Excretory System. 4 The Excretory System.notebook. May 24, 2017 4 The Excretry System.ntebk The Excretry System OSMOREGULATION (WATER BALANCE) Mst marine invertebrates are smcnfrmers, meaning the cncentratin f slutes in their bdy fluid is equal t that f their envirnment.

More information

Diabetologia 9 Springer-Verlag 1985

Diabetologia 9 Springer-Verlag 1985 Diabetlgia (1985) 28: 295-31 Diabetlgia 9 Springer-Verlag 1985 Effect f wrk-induced hypertrphy n muscle glucse metablism in lean and bese mice G. Augert 1, G. Van de Werve 2 and Y. Le Marchand-Brustel

More information

2017 Optum, Inc. All rights reserved BH1124_112017

2017 Optum, Inc. All rights reserved BH1124_112017 1) What are the benefits t clients f encuraging the use f MAT? Withut MAT, 90% f individuals with Opiid Use Disrder (OUD) will relapse within ne year. With MAT, the relapse rate fr thse with OUD decreases

More information

Oiabetologia 9 Springer-Verlag 1984

Oiabetologia 9 Springer-Verlag 1984 Diabetlgia (1984) 27:447-453 Oiabetlgia 9 Springer-Verlag 1984 Binding and mlecular weight prperties f the insulin receptr frm mental and subcutaneus adipcytes in human besity J. N. Livingstn 1, K. M.

More information

The data refer to persons aged between 15 and 54.

The data refer to persons aged between 15 and 54. Drug-related hspital stays in Australia 1993-2005 Prepared by Amanda Rxburgh and Luisa Degenhardt, Natinal Drug and Alchl Research Centre Funded by the Australian Gvernment Department f Health and Ageing

More information

Continuous Quality Improvement: Treatment Record Reviews. Third Thursday Provider Call (August 20, 2015) Wendy Bowlin, QM Administrator

Continuous Quality Improvement: Treatment Record Reviews. Third Thursday Provider Call (August 20, 2015) Wendy Bowlin, QM Administrator Cntinuus Quality Imprvement: Treatment Recrd Reviews Third Thursday Prvider Call (August 20, 2015) Wendy Bwlin, QM Administratr Gals f the Presentatin Review the findings f Treatment Recrd Review results

More information

Study Design Open, three arm-stratified, non-randomized, prospective, multicentric study

Study Design Open, three arm-stratified, non-randomized, prospective, multicentric study PONS Study Synpsis Title f the Study Subtype-Stratified Fllw-up Care Study f Breast Cancer Patients with Cmbined In Vitr and In Viv Diagnstics Plus Early Target-Oriented Interventin Gals Imprve and individualize

More information

Refining Blood Collection Techniques to Improve Animal Welfare and Sample Quality

Refining Blood Collection Techniques to Improve Animal Welfare and Sample Quality Refining Bld Cllectin Techniques t Imprve Animal Welfare and Sample Quality Amy Allaire RLATG 1, Jennifer Jhnsn 2, Kimberly Maratea DVM PhD 2, Steven Bulé CMAR RLATG 1, Sara Savage DVM DACLAM 1 1 Dispsitin,

More information

Q 5: Is relaxation training better (more effective than/as safe as) than treatment as usual in adults with depressive episode/disorder?

Q 5: Is relaxation training better (more effective than/as safe as) than treatment as usual in adults with depressive episode/disorder? updated 2012 Relaxatin training Q 5: Is relaxatin training better (mre effective than/as safe as) than treatment as usual in adults with depressive episde/disrder? Backgrund The number f general health

More information

Body Weight, Cerebral Atherosclerosis and Cerebral Vascular Disease: An Autopsy Study

Body Weight, Cerebral Atherosclerosis and Cerebral Vascular Disease: An Autopsy Study Bdy Weight, Cerebral Athersclersis and Cerebral Vascular Disease: An Autpsy Study BY A. C. KLASSEN, M.D., R. B. LOEWENSON, Ph.D., AND J. A. RESCH, M.D. Abstract: Bdy Weight, Cerebral A thersclersis and

More information

23/11/2015. Introduction & Aims. Methods. Methods. Survey response. Patient Survey (baseline)

23/11/2015. Introduction & Aims. Methods. Methods. Survey response. Patient Survey (baseline) Intrductin & Aims Drug and Alchl Cnsultatin Liaisn (AOD CL) services aim t imprve identificatin and treatment f patients with AOD mrbidity. The csts and cnsequences f targeting AOD patients presenting

More information